PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 67 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

18 July 2024

  1. (diff | hist) 14:52 Bacteriostatic water 1,850 ±0 FmocFrancis (talk | contribs) ce, tighten prose [rollback]
  2. (diff | hist) 12:29 Karl Fischer titration 2,412 +761 TechnicianTeal (talk | contribs) add short description [rollback]
  3. (diff | hist) 03:53 SUSTAIN trial programme 1,214 ±0 NNT_Nerys (talk | contribs) add the number randomised and the number completing [rollback]
  4. (diff | hist) N 00:27 Glucagon 1,645 +1,645 ShortDescShai (talk | contribs) start article on the compound

17 July 2024

  1. (diff | hist) 20:06 Incretin effect 2,353 ±0 ProglucagonPia (talk | contribs) clarify that the incretin effect is defined by the oral–intravenous comparison [rollback]
  2. (diff | hist) m b 19:54 Fmoc chemistry 1,950 +436 ArchiveBot (talk | contribs) bot: normalise unit spacing [rollback]
  3. (diff | hist) 16:40 Solid-phase peptide synthesis 1,893 ±0 PrepHPLC_Pia (talk | contribs) add the crimp-seal step to the fill-and-finish description [rollback]
  4. (diff | hist) N 10:38 SUSTAIN trial programme 1,214 +1,214 SurrogateSunday (talk | contribs) create article — trial programme stub
  5. (diff | hist) m 09:01 Retatrutide 2,444 +54 Chromatokid (talk | contribs) expand §Safety signals reported to date [rollback]
  6. (diff | hist) N 09:00 Lot traceability 1,389 +1,389 TelehealthTruus (talk | contribs) create article — testing stub

16 July 2024

  1. (diff | hist) m 21:08 Third-party testing 1,906 ±0 SupplyWatchSuri (talk | contribs) split overlong sentence [rollback]
  2. (diff | hist) N 16:03 Glossary of peptide terminology 1,029 +1,029 MolarMassMaeve (talk | contribs) start the list; inclusion criterion in the lead
  3. (diff | hist) m 10:33 Cold chain 5,128 ±0 GradientGus (talk | contribs) expand §Records and regulatory framing [rollback]
  4. (diff | hist) 07:35 Wuhan Wansheng Biotechnology 2,893 +38 COA_Colwyn (talk | contribs) add the registered legal name exactly as it appears in the registry record [rollback]
  5. (diff | hist) 03:21 Janoshik Analytical 1,290 ±0 PrimarySrcPatia (talk | contribs) add the note on how to request a batch record rather than a certificate [rollback]

15 July 2024

  1. (diff | hist) m 21:19 Adverse effects of GLP-1 receptor agonists 2,045 ±0 HypoHildur (talk | contribs) convert the adverse-event list to a table with both arms [rollback]
  2. (diff | hist) 08:59 Mass spectrometry 2,090 ±0 SigFigSindri (talk | contribs) expand §Ionisation and mass analysis [rollback]
  3. (diff | hist) m b 05:41 Reference standard 1,997 +808 CategoryBot (talk | contribs) bot: normalise citation format [rollback]

14 July 2024

  1. (diff | hist) 20:18 GL Biochem (Shanghai) 2,831 ±0 LotTraceLuka (talk | contribs) expand the product-scope row in the infobox [rollback]
  2. (diff | hist) m 00:48 Fmoc chemistry 1,514 ±0 DisparityDagny (talk | contribs) state that overlay gas is used and name it [rollback]

13 July 2024

  1. (diff | hist) m 22:25 Peptide synthesis 2,036 ±0 StateBoardStace (talk | contribs) copyedit [rollback]
  2. (diff | hist) 17:56 GLP-1 receptor agonist 2,788 ±0 FiveOhThreeB (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]
  3. (diff | hist) m 17:28 Guangzhou JEEP Biotechnology 2,709 ±0 BlindSampleBrid (talk | contribs) state the city and province of the registered address [rollback]
  4. (diff | hist) 06:33 STEP trial programme 2,343 ±0 DataTableDunja (talk | contribs) add the missing-data handling method [rollback]

12 July 2024

  1. (diff | hist) m 15:35 Enteroendocrine L cell 1,903 ±0 MazdutideMads (talk | contribs) convert the receptor-distribution list to a table [rollback]
  2. (diff | hist) 03:35 Glucose-dependent insulinotropic polypeptide 2,551 ±0 Chromatokid (talk | contribs) correct the second-messenger pathway named in the lead [rollback]
  3. (diff | hist) 01:17 Reverse-phase HPLC 2,305 +958 ResolutionRoo (talk | contribs) add the ionisation mode to the mass-spectrometry description [rollback]

11 July 2024

  1. (diff | hist) m 16:16 Peptide 2,306 +325 CDMO_Caradoc (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  2. (diff | hist) 15:55 Solid-phase peptide synthesis 1,893 ±0 MolarMassMaeve (talk | contribs) expand §Difficult sequences [rollback]
  3. (diff | hist) N 11:57 Janoshik Analytical 1,290 +1,290 CheckSumChase (talk | contribs) start article on the testing subject
  4. (diff | hist) m b 07:57 GLP-1 receptor 3,125 +294 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  5. (diff | hist) m 02:48 Reconstitution of lyophilised peptides 2,071 ±0 SharpsSukhi (talk | contribs) add category for preparation and handling [rollback]

10 July 2024

  1. (diff | hist) N 23:55 Guangzhou JEEP Biotechnology 2,709 +2,709 COA_Colwyn (talk | contribs) create organisation article per PP:VN
  2. (diff | hist) 15:18 Glucagon-like peptide-1 3,005 ±0 Chromatokid (talk | contribs) serial comma per PP:MOS [rollback]
  3. (diff | hist) 06:25 Reverse-phase HPLC 1,347 ±0 DiluentDiya (talk | contribs) add the note on co-elution and what it hides [rollback]
  4. (diff | hist) 03:46 High-performance liquid chromatography 2,620 +491 Retention_Time_Rae (talk | contribs) state the column chemistry and the gradient the figure was obtained on [rollback]
  5. (diff | hist) m 03:02 Peptide synthesis 2,036 ±0 StopperingSteff (talk | contribs) add category for logistics [rollback]

9 July 2024

  1. (diff | hist) 19:14 Wuhan Wansheng Biotechnology 2,855 +1,097 BlankVialBo (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]
  2. (diff | hist) 16:43 Proglucagon 1,868 +372 TrialsTabitha (talk | contribs) add category for receptor pharmacology [rollback]
  3. (diff | hist) m 09:47 Bacteriostatic water 1,850 ±0 MicrodoseMagnus (talk | contribs) add the disclaimer that this is not administration guidance [rollback]
  4. (diff | hist) N 09:00 Fmoc chemistry 1,514 +1,514 RepackRadek (talk | contribs) create article — process stub
  5. (diff | hist) 07:37 Retatrutide 2,390 ±0 OralSemaOswin (talk | contribs) give the isoelectric point with the method it was determined by [rollback]
  6. (diff | hist) m b 03:47 Adverse effects of GLP-1 receptor agonists 2,045 +733 ArchiveBot (talk | contribs) bot: sort category members [rollback]

8 July 2024

  1. (diff | hist) N 09:00 Proglucagon 1,496 +1,496 Chromatokid (talk | contribs) new article: incretin physiology, expansion welcome
  2. (diff | hist) m 08:11 Dipeptidyl peptidase-4 2,323 ±0 DrTitration (talk | contribs) clarify that the incretin effect is defined by the oral–intravenous comparison [rollback]
  3. (diff | hist) 00:10 Karl Fischer titration 1,651 ±0 GradientGus (talk | contribs) clarify the difference between related substances and total impurities [rollback]

7 July 2024

  1. (diff | hist) 23:11 Incretin effect 2,353 +512 ProglucagonPia (talk | contribs) rm the sentence implying the hormone is a drug [rollback]
  2. (diff | hist) 22:15 GL Biochem (Shanghai) 2,831 +1,033 ColdChainCleo (talk | contribs) add the research-use-only statement to the lead rather than only the footer [rollback]
  3. (diff | hist) 18:28 Retatrutide 2,390 ±0 DulaglutideDug (talk | contribs) state which salt form the mass in the infobox refers to [rollback]
  4. (diff | hist) 16:04 Semaglutide 3,178 +571 ComparisonCato (talk | contribs) close an unbalanced quotation mark [rollback]
  5. (diff | hist) m b 01:26 Mass spectrometry 2,090 ±0 CiteBot (talk | contribs) bot: repair redlinked category [rollback]
  6. (diff | hist) 00:28 Reference standard 1,189 ±0 DeletionDeb (talk | contribs) add the ionisation mode to the mass-spectrometry description [rollback]

6 July 2024

  1. (diff | hist) N 17:49 Reference standard 1,189 +1,189 EndpointEnid (talk | contribs) new article: analytical method, expansion welcome
  2. (diff | hist) N 09:00 Bacteriostatic water 1,850 +1,850 DiffWatchDov (talk | contribs) new article: dosing and handling, expansion welcome
  3. (diff | hist) 08:57 Talk:Bachem Holding (Suzhou) 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  4. (diff | hist) 08:57 Talk:ChinaPeptides 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  5. (diff | hist) 08:57 Talk:Chinese Peptide Company 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  6. (diff | hist) 08:57 Talk:Flourishglobal Peptide Biotech 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  7. (diff | hist) 08:57 Talk:GL Biochem (Shanghai) 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  8. (diff | hist) 08:57 Talk:Guangzhou JEEP Biotechnology 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  9. (diff | hist) 08:57 Talk:Hubei Jianxiang Bioscience 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  10. (diff | hist) 08:57 Talk:Hunan Aslsen Technology 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  11. (diff | hist) 08:57 Talk:Nantong Guangyuan Chemical 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  12. (diff | hist) 08:57 Talk:Qingdao Saber Technology Pharmaceutical 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  13. (diff | hist) 08:57 Talk:Qingdao Sigma Chemical 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  14. (diff | hist) 08:57 Talk:Sangon Biotech 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  15. (diff | hist) 08:57 Talk:Shanghai ERP Biotechnology 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  16. (diff | hist) 08:57 Talk:Shanghai Sigma-Audley New Material Technology 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  17. (diff | hist) 08:57 Talk:Shanghai Wibson Biotechnology 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  18. (diff | hist) 08:57 Talk:Tianjin Finder Chemical 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  19. (diff | hist) 08:57 Talk:Wuhan Wansheng Biotechnology 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  20. (diff | hist) 08:57 Talk:WuXi TIDES 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  21. (diff | hist) 08:57 Talk:Xi'an Mokemei Biotechnology 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply
  22. (diff | hist) 08:57 Talk:Zhuhai Kerui Biotechnology 1,307 +122 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ reply

5 July 2024

  1. (diff | hist) 10:23 Talk:Bachem Holding (Suzhou) 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  2. (diff | hist) 10:23 Talk:ChinaPeptides 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  3. (diff | hist) 10:23 Talk:Chinese Peptide Company 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  4. (diff | hist) 10:23 Talk:Flourishglobal Peptide Biotech 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  5. (diff | hist) 10:23 Talk:GL Biochem (Shanghai) 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  6. (diff | hist) 10:23 Talk:Guangzhou JEEP Biotechnology 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  7. (diff | hist) 10:23 Talk:Hubei Jianxiang Bioscience 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  8. (diff | hist) 10:23 Talk:Hunan Aslsen Technology 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  9. (diff | hist) 10:23 Talk:Nantong Guangyuan Chemical 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  10. (diff | hist) 10:23 Talk:Qingdao Saber Technology Pharmaceutical 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  11. (diff | hist) 10:23 Talk:Qingdao Sigma Chemical 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  12. (diff | hist) 10:23 Talk:Sangon Biotech 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  13. (diff | hist) 10:23 Talk:Shanghai ERP Biotechnology 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  14. (diff | hist) 10:23 Talk:Shanghai Sigma-Audley New Material Technology 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  15. (diff | hist) 10:23 Talk:Shanghai Wibson Biotechnology 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  16. (diff | hist) 10:23 Talk:Tianjin Finder Chemical 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  17. (diff | hist) 10:23 Talk:Wuhan Wansheng Biotechnology 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  18. (diff | hist) 10:23 Talk:WuXi TIDES 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  19. (diff | hist) 10:23 Talk:Xi'an Mokemei Biotechnology 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  20. (diff | hist) 10:23 Talk:Zhuhai Kerui Biotechnology 1,096 +156 Hedgerow_Hal (talk | contribs) /* Standing note: what this article may not contain */ reply
  21. (diff | hist) 00:58 STEP trial programme 2,343 +1,044 ColdChainCleo (talk | contribs) de-duplicate a repeated sentence [rollback]
  22. (diff | hist) N 00:34 Enteroendocrine L cell 1,903 +1,903 PriorAuthPaz (talk | contribs) start article on the hormone

4 July 2024

  1. (diff | hist) N 12:52 Karl Fischer titration 1,651 +1,651 ColdChainCleo (talk | contribs) start article on the analytical method
  2. (diff | hist) 11:48 Talk:Bachem Holding (Suzhou) 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  3. (diff | hist) 11:48 Talk:ChinaPeptides 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  4. (diff | hist) 11:48 Talk:Chinese Peptide Company 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply